Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Helicos ready to launch Heliscope! Stock market reacts 24 hours early!

    According to their presentation at the JP Morgan Healthcare Conference today, Helicos is ready to launch nearly nine instruments, for which they have no orders for. Please read the full report over at Genome Web: http://www.genomeweb.com/issues/news/144376-1.html

    I have a couple things to say here...the first of which is I am intrigued by the 40% jump in HLCS stock starting yesterday afternoon, on absolutely no news, other than the the DOW in general rallied in the afternoon. Looks like the news of this "launch is still a go" announcement leaked out something fierce.



    Also, I'm still waiting for a publication or any in depth treatment on how the Heliscope chemistry works. Compared to the pre-launch environment of the SOLiD system, Helicos has publicized virtually nothing about the chemistry, even in broad strokes.

    It's a bit disturbing that they are ready to launch the instrument but haven't published any data nor identified any pre-launch instrument placements.

    Their recent announcement of a $20M loan from GE leaves me wondering if they are close to death....if their cash burn rate was ~$10 million in Q3-2007, I would expect it to be significantly higher than that for Q4-2007 and Q1-2008. Meaning that $20M ain't going to last that long.

    But if I'm mistaken on any of these points, I would be glad to hear it (*hint*...register and post! )

  • #2
    To respond to myself, I was mistaken. Apparently the market reaction on Jan 9 was based on data that Helicos published in their 8K released on Jan 9:

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Current Approaches to Protein Sequencing
      by seqadmin


      Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
      04-04-2024, 04:25 PM
    • seqadmin
      Strategies for Sequencing Challenging Samples
      by seqadmin


      Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
      03-22-2024, 06:39 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 04-11-2024, 12:08 PM
    0 responses
    18 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 10:19 PM
    0 responses
    22 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 09:21 AM
    0 responses
    17 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-04-2024, 09:00 AM
    0 responses
    48 views
    0 likes
    Last Post seqadmin  
    Working...
    X